US$ 21.11
bpc-157 vs tb-500 peptide comparison Therapy for Inflammation: A New Solution BPC-157 vs. TB-500 | Peptides
Description
BPC-157: Potential benefits and current evidence

Animal studies on BPC-157 have demonstrated a favorable safety profile, with no established LD50 (lethal dose) and no documented organ toxicity, carcinogenicity, or mutagenicity at tested doses

If I am late taking the shot I start to feel sluggish

PubMed , TCN1 Transcobalamin 1 [Homo Sapiens (Human)] Gene NCBI
